Cheyenne Wyoming, Aug. 15, 2016 (GLOBE NEWSWIRE) --
MedX Holdings, Inc. (OTC PINK: MEDH) MEDX, our wholly-owned subsidiary has successfully secured a sales office in Fort Lauderdale Florida, 1500 W. Cypress Creek Rd, Suite 302 Fort Lauderdale, FL. Beginning this week, our sales team goes live on the phones to give birth to the revenue phase for both MedX Holdings and MedX Pharmaceuticals. We have accomplished this in record time, which has the entire executive team amazed. MedX took possession of our Office/Warehouse on July 1, 2016. We then remodeled it completely to pass inspection by July 27, 2016 and were licensed as a Manufacturer, Wholesaler, and Repackager on July 29, 2016. Next we took possession of our new Sales Office in Florida on August 1, 2016 and in less than 2 weeks we have it fully staffed with superior sales associates and completely set up ready to rock the phones!
In addition, we will have a brand new updated state-of-the art website that will go live no later than 8/17/2016. Please check www.medxholdings.com and www.medxpharmaceuticals.com in the very near future!
Finally, Kathleen Roberton has relocated her residence, and is now living full time in Mobile, Alabama a mere 5 miles from the 1st fully-licensed distribution warehouse in order to be very “hands-on” during the initial ramp up of sales. Ms. Roberton, CEO commented: “We have spent the first half of the year building a very firm solid foundation, now it is time to focus in on sales and share price, something very important to all of us!”
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MedX Pharmaceuticals, a wholly-owned subsidiary of MEDH, is newly emerging as a dynamic distributor of an array of future pharmaceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
Phone: 877-225-0243 Email: firstname.lastname@example.org
Source:MedX Holdings, Inc.